Investigation of Metabolic Stability of Phase Ⅰ and Ⅱ Sulfation of Lucidin in Liver Microsomes and Liver S9 from Different Species

Yuexin MA; Ying ZHANG; Jing YANG; Youlong FENG; Qing HUANG; Ling CAO

doi:10.13422/j.cnki.syfjx.20220347

您当前的位置：

首页 >

文章列表页 >

Investigation of Metabolic Stability of Phase Ⅰ and Ⅱ Sulfation of Lucidin in Liver Microsomes and Liver S9 from Different Species

更新时间：2022-09-30

- Investigation of Metabolic Stability of Phase Ⅰ and Ⅱ Sulfation of Lucidin in Liver Microsomes and Liver S9 from Different Species
  增强出版
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 28, Issue 21, Pages: 113-120(2022)
- 作者机构：
  
  1.南京中医药大学药学院，南京 210023
  2.江苏省食品药品监督检验研究院，南京 210019
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20220347
  CLC： R22;R28;R96;Q485
- Received：15 December 2021，
  
  Published Online：15 February 2022，
  
  Published：05 November 2022
- 稿件说明：
移动端阅览
马跃新,张莹,杨静等.芦西丁在不同种属肝微粒体和肝S9中Ⅰ相代谢及Ⅱ相磺酸化代谢的稳定性考察[J].中国实验方剂学杂志,2022,28(21):113-120.

MA Yuexin,ZHANG Ying,YANG Jing,et al.Investigation of Metabolic Stability of Phase Ⅰ and Ⅱ Sulfation of Lucidin in Liver Microsomes and Liver S9 from Different Species[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(21):113-120.
马跃新,张莹,杨静等.芦西丁在不同种属肝微粒体和肝S9中Ⅰ相代谢及Ⅱ相磺酸化代谢的稳定性考察[J].中国实验方剂学杂志,2022,28(21):113-120. DOI： 10.13422/j.cnki.syfjx.20220347.

MA Yuexin,ZHANG Ying,YANG Jing,et al.Investigation of Metabolic Stability of Phase Ⅰ and Ⅱ Sulfation of Lucidin in Liver Microsomes and Liver S9 from Different Species[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(21):113-120. DOI： 10.13422/j.cnki.syfjx.20220347.

摘要

目的

采用4个种属体外肝微粒体和肝S9孵育体系评价芦西丁Ⅰ相代谢、Ⅱ相磺酸化代谢稳定性，比较其体外代谢的种属差异。

方法

建立并验证了基于超高效液相色谱-高分辨质谱法（UHPLC-HRMS）的芦西丁定性、定量检测方法，将芦西丁与大鼠、小鼠、比格犬、人肝微粒体和肝S9分别进行孵育，考察其代谢稳定性参数、代谢产物和代谢途径。

结果

在Ⅰ相和Ⅱ相磺酸化孵育体系中，芦西丁代谢的肝清除率大小排序为小鼠>大鼠>比格犬>人，在大鼠、比格犬、人肝微粒体和肝S9中，其代谢稳定性均良好，而在小鼠肝微粒体和肝S9中，分别表现为代谢不稳定和代谢稳定性中等；在4个种属中快速识别了5个代谢产物，其中Ⅰ相氧化产物3个，Ⅱ相磺酸化产物2个，代谢产物的生成速率与代谢稳定性结果较为一致。

结论

建立的UHPLC-HRMS简便、专属性强，可用于芦西丁的代谢稳定性和代谢产物研究。芦西丁Ⅰ相和Ⅱ相磺酸化的体外代谢稳定性、代谢产物生成速率存在明显的种属差异，其在人、大鼠、比格犬中的代谢特征较为相近，可为芦西丁体内代谢研究、安全性评价及动物模型选择提供参考依据。

Abstract

Objective

To evaluate the metabolic stability of lucidin by incubating liver microsomes and liver S9 from 4 species， and to compare the species differences in metabolism of lucidin

in vitro

Method

A qualitative and quantitative method of lucidin based on ultra-high performance liquid chromatography-high resolution mass spectrometry （UHPLC-HRMS） was established and verified. Lucidin was incubated with rat， mouse， beagle dog， human liver microsomes and liver S9 to investigate the metabolic stability parameters， metabolites， metabolic pathways.

Result

Hepatic clearance （CL

） of lucidin was in order of mouse

rat

beagle dog

human in both phase Ⅰ and phase Ⅱ incubation system. Its metabolic stability was good in rat， beagle dog and human， while it showed metabolic instability and moderate metabolic stability in mouse microsomes and liver S9， respectively. A total of 5 metabolites were rapidly identified， including 3 oxidation metabolites of phase Ⅰ and 2 sulfation metabolites of phase Ⅱ. The production rate of metabolites was consistent with the results of metabolic stability.

Conclusion

The established UHPLC-HRMS is simple and specific， which can be used for the study on the metabolic stability and metabolites of lucidin. Its metabolic stability and metabolite production rate

in vitro

are significantly different among species， the metabolic characteristics of rat and beagle dog are similar to human， which provides an important reference for subsequent research

in vivo

， safety evaluation and animal model selection of lucidin.

关键词

Keywords

references

MORGAN I ， WESSJOHANN L A ， KALUDEROVIC G N . In vitro anticancer screening and preliminary mechanistic study of a-ring substituted anthraquinone derivatives ［J］. Cells ， 2021 ， 11 （ 1 ）： 168 .

ISHII Y ， INOUE K ， TAKASU S ， et al . Determination of lucidin-specific DNA adducts by liquid chromatography with tandem mass spectrometry in the livers and kidneys of rats given lucidin-3- O -primeveroside ［J］. Chem Res Toxicol ， 2012 ， 25 （ 5 ）： 1112 - 1118 .

CHAO P Y ， USS A S ， CHENG K C . Use of intrinsic clearance for prediction of human hepatic clearance ［J］. Expert Opin Drug Metab Toxicol ， 2010 ， 6 （ 2 ）： 189 - 198 .

ISHII Y ， TAKASU S ， KURODA K ， et al . Combined application of comprehensive analysis for DNA modification and reporter gene mutation assay to evaluate kidneys of gpt delta rats given madder color or its constituents ［J］. Anal Bioanal Chem ， 2014 ， 406 （ 9/10 ）： 2467 - 2475 .

WORLD HEALTH ORGANIZATION ， INTERNATIONAL AGENCY for RESEARCH on CANCER . IARC monographs on the evaluation of carcinogenic risks to humans：Some traditional herbal medicines，some mycotoxins，naphthalene and styrene ［M］. Lyon ： IARC Press ， 2002 ， 82 ： 147 .

INOUE K ， YOSHIDA M ， TAKAHASHI M ， et al . Induction of kidney and liver cancers by the natural food additive madder color in a two-year rat carcinogenicity study ［J］. Food Chem Toxicol ， 2009 ， 47 （ 1 ）： 184 - 191 .

REN G H ， CHEN H L ， ZHANG M ， et al . Pharmacokinetics，tissue distribution and excretion study of oroxylin A，oroxylin A 7- O -glucuronide and oroxylin A sodium sulfonate in rats after administration of oroxylin A ［J］. Fitoterapia ， 2020 ， 142 ： 104480 .

LIANG S C ， XIA Y L ， HOU J ， et al . Methylation，glucuronidation，and sulfonation of daphnetin in human hepatic preparations in vitro ：Metabolic profiling，pathway comparison，and bioactivity analysis ［J］. J Pharm Sci ， 2016 ， 105 （ 2 ）： 808 - 816 .

OKUNO Y ， BONALA R ， ATTALURI S ， et al . Bioactivation mechanisms of N -hydroxyaristolactams：Nitroreduction metabolites of aristolochic acids ［J］. Environ Mol Mutagen ， 2019 ， 60 （ 9 ）： 792 - 806 .

熊爱珍，杨莉，张芳，等 . LC-MS n 鉴定肝毒性吡咯里西啶类生物碱千里光碱大鼠体内代谢产物［J］. 中国药学杂志， 2012 ， 47 （ 1 ）： 54 - 60 .

ISHII Y ， KIJIMA A ， TAKASU S ， et al . Effects of inhibition of hepatic sulfotransferase activity on renal genotoxicity induced by lucidin-3- O -primeveroside ［J］. J Appl Toxicol ， 2019 ， 39 （ 4 ）： 650 - 657 .

SACHSE B ， MEINL W ， GLATT H ， et al . The effect of knockout of sulfotransferases 1A1 and 1D1 and of transgenic human sulfotransferases 1A1/1A2 on the formation of DNA adducts from furfuryl alcohol in mouse models ［J］. Carcinogenesis ， 2014 ， 35 （ 10 ）： 2339 - 2345 .

TANEJA I ， KARSAULIYA K ， RASHID M ， et al . Species differences between rat and human in vitro metabolite profile， in vivo predicted clearance，CYP450 inhibition and CYP450 isoforms that metabolize benzanthrone：Implications in risk assessment ［J］. Food Chem Toxicol ， 2018 ， 111 ： 94 - 101 .

郭兆娟，张晶璇，康倩君，等 . 补骨脂对大鼠、小鼠肝毒性的比较［J］. 中国实验方剂学杂志， 2020 ， 26 （ 22 ）： 16 - 25 .

SŁOCZYŃSKA K ， GUNIA-KRZYŻAK A ， KOCZURKIEWICZ P ， et al . Metabolic stability and its role in the discovery of new chemical entities ［J］. Acta Pharm ， 2019 ， 69 （ 3 ）： 345 - 361 .

刘琼艳，张美琴，卿晨，等 . 喜树碱衍生物NCP4在不同种属肝微粒体中代谢稳定性研究［J］. 天然产物研究与开发， 2019 ， 31 （ 11 ）： 1968 - 1974 .

BARANCZEWSKI P ， STAŃCZAK A ， SUNDBERG K ， et al . Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development ［J］. Pharmacol Rep ， 2006 ， 58 （ 4 ）： 453 - 472 .

张丽，蔡进，班玉娟，等 . 采用UPLC-MS/MS法研究树豆酮酸A在不同种属肝微粒体中的代谢差异［J］. 中国药房， 2019 ， 30 （ 18 ）： 2497 - 2502 .

刘梦娇，王云，李玲云，等 . 三黄片化学成分的UPLC-Q-TOF-MS/MS快速鉴定分析［J］. 中国中药杂志， 2017 ， 42 （ 9 ）： 1685 - 1692 .

罗思妮，彭致铖，范倩，等 . 经典名方小承气汤中化学成分的UPLC-Q-Orbitrap-MS分析［J］. 中国实验方剂学杂志， 2021 ， 27 （ 23 ）： 1 - 10 .

牛燕燕，陈光英，罗由萍，等 . 密度泛函理论辅助研究大黄素型蒽醌化合物电喷雾质谱的裂解过程［J］. 分析科学学报， 2017 ， 33 （ 3 ）： 367 - 372 .

刘志宝，吴耽，唐娟，等 . 辛芍组方效应成分在正常和脑缺血再灌注损伤大鼠肝微粒体中的酶促反应动力学分析［J］. 中国实验方剂学杂志， 2019 ， 25 （ 1 ）： 169 - 176 .

黄凯，刘志浩，贺晴 . 黄芩苷对大鼠和人肝微粒体CYP450酶的抑制作用［J］. 中国实验方剂学杂志， 2016 ， 22 （ 3 ）： 20 - 23 .

DIAO X ， PANG X ， XIE C ， et al . Bioactivation of 3- N -butylphthalide via sulfation of its major metabolite 3-hydroxy-NBP：Mediated mainly by sulfotransferase 1A1 ［J］. Drug Metab Dispos ， 2014 ， 42 （ 4 ）： 774 - 781 .

HASHIMOTO K ， ZAITSEVA I N ， BONALA R ， et al . Sulfotransferase-1A1-dependent bioactivation of aristolochic acid Ⅰ and N -hydroxyaristolactam Ⅰ in human cells ［J］. Carcinogenesis ， 2016 ， 37 （ 7 ）： 647 - 655 .

GAN J P ， MA S G ， ZHANG D L . Non-cytochrome P450-mediated bioactivation and its toxicological relevance ［J］. Drug Metab Rev ， 2016 ， 48 （ 4 ）： 473 - 501 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Application of Self-assembled Nano-strategies of Traditional Chinese Medicine in Tumor Therapy： A Review

Development of Fucosterol Certified Reference Material

Analysis on Chemical Constituents in Xiao Chengqitang by UPLC-Q-Orbitrap-MS

Quality Control of Dynamic Volatile Components in Lonicerae Japonicae Flos and Lonicerae Flos

Analysis of in Vivo and in Vitro Metabolites of Coptisine in Rats by HPLC-MS/MS

Related Author

HUANG Ju

ZHU Yu

XIAO Hang

LI Songtao

LIU Jingwen

ZHENG Qiao

MENG Xiangrui

TANG Jianyuan

Related Institution

School of TCM，Capital Medical University

Hospital of Chengdu University of Traditional Chinese Medicine （TCM）

Technology Innovation Center for Exploitation and Utilization of Marine Biological Resources， Third Institute of Oceanography，Ministry of Natural Resources

Institute of Chinese Materia Medica，China Academy of Chinese Medical Sciences

School of Chemical Engineering，Huaqiao University

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰